Top 10 developments in lupus nephritis.

about

Renal transplantation in systemic lupus erythematosus: outcome and prognostic factors in 50 cases from a single centre.Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus.

P2860

Q33810462-21F7EE45-5DB0-4114-BA7B-7C0DAC892FB2 Q46173910-993C7EE0-6377-4B8A-A736-32F05B7F8A1C

P2860

Top 10 developments in lupus nephritis.

Item

http://www.wikidata.org/entity/Q38124761

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Top 10 developments in lupus nephritis.

@en

type

Item

label

Top 10 developments in lupus nephritis.

@en

prefLabel

Top 10 developments in lupus nephritis.

@en

P1476

Top 10 developments in lupus nephritis.

@en

P2093

Derek M Fine

http://www.w3.org/2001/XMLSchema#string

Teresa K Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

P2888

s11926-013-0358-7

P304

358

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11926-013-0358-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253335465

http://www.w3.org/2001/XMLSchema#string

P6179

1015963945

http://www.w3.org/2001/XMLSchema#string

P698

23893235

http://www.w3.org/2001/XMLSchema#string

Top 10 developments in lupus nephritis.

about

P2860

P2860

Top 10 developments in lupus nephritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698